An increasingly popular topic in our national news is the pricing of pharmaceutical drugs in North America. Our drug prices increase annually and are drastically higher in almost all categories than most, if not all other developed countries. Access to healthcare and price varies depending on your location in the United States but chronic eye disease does not vary from place to place. According to new Medicare data, the way doctors treat chronic eye disease does differ from location to location and those changes have major effects on personal and US budgets.
The map above shows the use of Lucentis a drug used to treat eye disease differs from area to area. The brightest reds show places where the vast majority of the money spent in treating the disease is spent on Lucentis; the deepest blues, shows places where most of the money spent treating the disease is spent on its cheaper alternatives.Such variety in treatment calls into question whether doctors are treating patients based on the best available evidence, or other considerations.
Rich, Steven. "These maps tell you everything that’s wrong with our drug pricing system." The Washington Post. WP Company, 11 Apr. 2014. Web. 27 Feb. 2017.